China vs Netherlands: Getting credit: Strength of legal rights index (0-10) (DB05-14)
China
40
in 2013
Netherlands
40
in 2013
China rank
127th
Netherlands rank
127th
Getting credit: Strength of legal rights index (0-10) (DB05-14) over time
- China
- Netherlands
How they compare
China currently reports 40 against 40 in Netherlands, a difference of 0.
Across all 10 years both countries report, Netherlands has been ahead every year.
China ranks 127th and Netherlands ranks 127th of 184 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.33 | 50 | 21.67 | Netherlands |
| 2010s | 40 | 47.5 | 7.5 | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher getting credit: strength of legal rights index (0-10) (db05-14), China or Netherlands?
- China, at 40 against 40 in Netherlands as of 2013.
- What is the difference in getting credit: strength of legal rights index (0-10) (db05-14) between China and Netherlands?
- 0, with China ahead.
- How many years of comparable data are there for China and Netherlands?
- 10 years are reported by both, from 2004 to 2013.
- How do China and Netherlands rank globally for getting credit: strength of legal rights index (0-10) (db05-14)?
- China ranks 127th and Netherlands ranks 127th of 184 countries.
- Where does this data come from?
- The World Bank, published as Getting credit: Strength of legal rights index (0-10) (DB05-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for the strength of legal rights benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB05-14 studies.